17 insiders have filed at CLOV since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Toy Andrew | Chief Executive Officer | 9.42M | 1.77% | ||
| Kuipers Peter J. | Chief Financial Officer | 5.76M | 1.081% | ||
| Leffler Scott J. | Chief Financial Officer | 4.86M | 0.912% | ||
| Clover Health Investments, Corp. /De | Chief Technology Officer | 3.09M | 0.581% | ||
| Reynoso Jamie L. | CEO, Medicare Advantage | 2.72M | 0.51% | 12 sells $350k | |
| Wai Conrad | CEO, Counterpart Health | 2.54M | 0.476% | 2 sells $693k | |
| Sharp Aric R | CEO Of Value Based Care | 2.10M | 0.394% | ||
| Priest Brady Patrick | CEO Of Home Care | 2.00M | 0.375% | 2 sells $656k | |
| Garipalli Vivek | Director | 1.86M | 0.349% | 4 buys $3.0M | |
| Soares Karen | General Counsel & Secretary | 1.20M | 0.225% | 1 sells $200k | |
| Kouzoukas Demetrios L. | Director | 606.0k | 0.114% | ||
| Clinton Chelsea | Director | 602.8k | 0.113% | ||
| Shapiro Lee | Director | 598.6k | 0.112% | ||
| Robinson William G JR | Director | 598.0k | 0.112% | ||
| Loengard Anna U | Director | 584.7k | 0.11% | 10 buys $219k | |
| Edwards Carladenise Armbrister | Director | 352.6k | 0.066% | 1 sells $722k | |
| Tran Thomas L | Director | 180.0k | 0.034% |
Full register at boothcheck.com/insiders/CLOV. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.